UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

Amazon has responded to tariff concerns by leaning on its third-party sellers, who bulked up inventory to maintain pricing ...

Nebula Research & Development LLC more than doubled its Chevron holdings in Q4, snapping up 5,165 additional shares worth ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...

The Manufacturers Life Insurance Company reduced its Home Depot holdings by 4.7% in Q4, selling 38,498 shares. This left the ...

JPMorgan Chase strutted into Q1 2025 with a financial performance that deserves a standing ovation and maybe a bonus or two.

Merck & Co. is caught in the middle of Wall Street's version of a group chat disagreement. Analysts gave it a “Moderate Buy” ...

Walmart saw a small trim in its holdings by Beacon Pointe Advisors, who offloaded 22,795 shares in Q4, though the retailer ...